DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+15%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.15B
AUM Growth
+$2.15B
(-15%)
Cap. Flow
-$626M
Cap. Flow
% of AUM
-29.09%
Top 10 Holdings %
Top 10 Hldgs %
42.88%
Holding
121
New
14
Increased
12
Reduced
29
Closed
26
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$56M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$44.6M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$25M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$24.3M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$19.4M |
Top Sells
Sector Composition
| 1 | Healthcare | 70.12% |
| 2 | Financials | 3.34% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Editas Medicine
EDIT
$225M
| $23M | 1.07% |
1,709,400
| – | – |
|
|
ONCE
27
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $22.1M | 1.03% |
368,000
| – | – |
|
|
28
BioCryst Pharmaceuticals
BCRX
$1.74B
| $19.4M | 0.9% |
+4,401,846
| New | +$19.4M |
|
29
Glaukos
GKOS
$5.42B
| $19M | 0.88% |
503,277
-480,835
| -49% | -$18.1M |
|
30
Select Medical
SEM
$1.6B
| $18.3M | 0.85% |
1,354,662
+37,718
| +3% | +$509K |
|
|
IVTY
31
DELISTED
Invuity, Inc
IVTY
| $17.6M | 0.82% |
1,282,598
-44,411
| -3% | -$609K |
|
32
Axogen
AXGN
$718M
| $17.1M | 0.8% |
1,893,030
-1,488,409
| -44% | -$13.4M |
|
|
FPRX
33
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $16.3M | 0.76% |
311,000
-137,000
| -31% | -$7.19M |
|
|
BLUE
34
DELISTED
bluebird bio
BLUE
| $15.2M | 0.71% |
224,000
-114,085
| -34% | -$7.73M |
|
35
CytomX Therapeutics
CTMX
$350M
| $14.8M | 0.69% |
943,433
| – | – |
|
36
Protara Therapeutics
TARA
$125M
| $14.7M | 0.68% |
1,570,467
+18,436
| +1% | +$172K |
|
|
FOMX
37
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $12.1M | 0.56% |
1,307,058
+25,000
| +2% | +$231K |
|
|
ARRY
38
DELISTED
Array Biopharma Inc
ARRY
| $11.1M | 0.52% |
1,650,000
-6,711,069
| -80% | -$45.3M |
|
|
AKTX
39
Akari Therapeutics
AKTX
$21.4M
| $9.79M | 0.46% |
1,150,700
| – | – |
|
|
ALIM
40
DELISTED
Alimera Sciences, Inc.
ALIM
| $8.76M | 0.41% |
5,878,015
| – | – |
|
|
MYOK
41
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.17M | 0.38% |
499,800
+125,000
| +33% | +$2.04M |
|
42
Ardelyx
ARDX
$1.57B
| $8.01M | 0.37% |
618,643
+343,643
| +125% | +$4.45M |
|
|
ARLZ
43
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $7.98M | 0.37% |
1,644,583
| – | – |
|
|
STJ
44
DELISTED
St Jude Medical
STJ
| $7.98M | 0.37% |
+100,000
| New | +$7.98M |
|
|
SIOX
45
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $7.95M | 0.37% |
+568,005
| New | +$7.95M |
|
46
Exact Sciences
EXAS
$9.33B
| $6.64M | 0.31% |
+357,680
| New | +$6.64M |
|
|
LOXO
47
DELISTED
Loxo Oncology, Inc
LOXO
| $6.57M | 0.31% |
251,000
| – | – |
|
|
BPMC
48
DELISTED
Blueprint Medicines
BPMC
| $6.4M | 0.3% |
+215,586
| New | +$6.4M |
|
|
STDY
49
DELISTED
SteadyMed Ltd
STDY
| $6.31M | 0.29% |
1,756,370
+409,626
| +30% | +$1.47M |
|
|
OXFD
50
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.84M | 0.27% |
464,541
| – | – |
|